Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Maisa C. Takenaka(Brigham and Women's Hospital), Francisco J. Quintana(Hospital Prof. Dr. Fernando Fonseca), Sonja Rothweiler(Beth Israel Deaconess Medical Center), Kalil Alves de Lima(Brigham and Women's Hospital), Andréia Barroso(Brigham and Women's Hospital), Mauricio Farez(Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Galina Gabriely(Brigham and Women's Hospital), Veit Rothhammer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jessica E. Kenison(Brigham and Women's Hospital), Luke M. Healy(Montreal Neurological Institute and Hospital), Cristina Gutiérrez‐Vázquez(Brigham and Women's Hospital), Michael A. Wheeler(Brigham and Women's Hospital), Simon C. Robson(Beth Israel Deaconess Medical Center), Lior Mayo(Tel Aviv University), Soufiene Ghannam(Université de Montréal), Jack P. Antel(Montreal Neurological Institute and Hospital), Stéphanie Zandee(Centre Hospitalier de l’Université de Montréal), David A. Reardon(Dana-Farber Cancer Institute), Tyler Vandeventer(Brigham and Women's Hospital), David H. Sherr(Boston University), Howard L. Weiner(Baylor College of Medicine), Hailei Zhang(Hebei University), Alexandre Prat(Université de Montréal), Iván Mascanfroni(Brigham and Women's Hospital), Chun‐Cheih Chao(Brigham and Women's Hospital), Emily Tjon(Brigham and Women's Hospital), Gad Getz(Broad Institute)
Cited by 528
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
The Blood–Brain Barrier
|Cold Spring Harbor Perspectives in Biology|2015|3.2k